Publications by authors named "Guenter Blaich"

Claim this Profile
N
Nonclinical Development of Biologics: Integrating Safety, Pharmacokinetics, and Pharmacodynamics to Create Smarter and More Flexible Nonclinical Safety Programs Optimizing Animal Use.
Adam Hey, Andreas Baumann, Sven Kronenberg, Guenter Blaich, Silke Mohl

Int J Toxicol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership Meeting.
Thomas Kissner, Guenter Blaich, Andreas Baumann, Sven Kronenberg, Adam Hey

MAbs· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotherapeutics in non-clinical development: Strengthening the interface between safety, pharmacokinetics-pharmacodynamics and manufacturing.
Peter Ulrich, Guenter Blaich, Andreas Baumann, Rajni Fagg, Adam Hey

Regul Toxicol Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Blockade of Interleukin-1 and Interleukin-17A Reduces Murine Arthritis Pathogenesis but Also Leads to Spontaneous Skin Infections in Nonhuman Primates.
Melanie C Ruzek, Lili Huang, Ting-Ting Zhang, Shaughn Bryant, Peter F Slivka, Guenter Blaich

J Pharmacol Exp Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leverage nonclinical development of bispecifics by translational science.
Andreas Baumann, Stephanie Fischmann, Guenter Blaich, Matthias Friedrich

Drug Discov Today Technol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-clinical Safety Evaluation of Biotherapeutics - Challenges, Opportunities and new Insights.
Guenter Blaich, Andreas Baumann, Sven Kronenberg, Lolke de Haan, Peter Ulrich

Regul Toxicol Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical safety testing of biopharmaceuticals--Addressing current challenges of these novel and emerging therapies.
Frank R Brennan, Andreas Baumann, Guenter Blaich, Lolke de Haan, Rajni Fagg

Regul Toxicol Pharmacol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody.
Brian P Enright, Belen Tornesi, Gerhard F Weinbauer, Guenter Blaich

Birth Defects Res B Dev Reprod Toxicol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male and female fertility assessment in the cynomolgus monkey following administration of ABT-874, a human Anti-IL-12/23p40 monoclonal antibody.
Brian P Enright, Belen Tornesi, Gerhard F Weinbauer, Guenter Blaich

Birth Defects Res B Dev Reprod Toxicol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental and reproductive toxicology studies in IL-12p40 knockout mice.
Brian P Enright, Donna R Davila, Belen M Tornesi, Guenter Blaich, Alan M Hoberman

Birth Defects Res B Dev Reprod Toxicol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis